The median CD4+ T-cell count was 59 cells/μL (IQR: 32-120), and 72.2% (39/54) had a CD4+ count of less than 200 cells/μL; 31.4% (17/54) of patients with a history of HIV infection were receiving antiretroviral therapy. This evidence concerns the gene CD4 and HIV infectious disease.